Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 [Phase 1]
Phase 1/1b trial evaluating RNDO-564 as a single agent or in combination with pembrolizumab in bladder cancer and nectin-4–associated solid …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Phase 3]
Clinical trial update for a Phase 3 study of nivolumab and ipilimumab with or without local consolidation therapy in patients with Stage IV …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC [Phase 2]
Phase 2 trial evaluating healthy donor fecal microbiota transplant in combination with pembrolizumab for relapsed/refractory PD-L1 positive …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]
AZD8205 is being studied in a Phase I/IIa trial as a single agent or in combination for advanced/metastatic solid tumors. Recruitment is ong…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of cabozantinib (XL184) and nivolumab in patients with various advanced cancers …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial update evaluating megestrol acetate as first-line treatment for malnourished non-small cell lung cancer; the study …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer [Phase 2]
A Phase 2 trial is evaluating starting durvalumab after chemoradiation in patients with unresectable stage III non-small cell lung cancer. T…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) [Phase 2]
A Phase 2 clinical trial update on pembrolizumab (Keytruda) for previously treated stage IV nonsquamous non-small cell lung cancer, currentl…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: BBO-11818 in Adult Subjects With KRAS Mutant Cancer [Phase 1]
Phase 1 trial update for BBO-11818 in adults with KRAS-mutant cancers, currently recruiting across several KRAS-driven solid tumors includin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial) [Phase 2]
This Clinical Trials update describes the Phase 2 A LUNG-MAP trial evaluating targeted therapy for RET fusion-positive advanced non-small ce…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC [Phase 2]
A Phase 2 study called Symbiotic-Lung-10 evaluating PF-08634404 alone or with a partner in early-stage or locally advanced non-small cell lu…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial using electronic nose (E-Nose) technology to monitor treatment response in patients with non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab [Phase 2]
A Phase 2 trial update evaluating how well Zongertinib is tolerated when given in combination with chemotherapy with or without pembrolizuma…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: PET-CT Predicting Lymph Nodes Metastasis
Clinical trial update from Fudan University describes PET-CT as a potential predictor of lymph node metastasis in non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors [Phase 1]
Phase 1 clinical trial update evaluating the safety and tolerability of the radiopharmaceutical 212Pb-DOTAM-GRPR1 in adults with recurrent o…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations [Phase 3]
Phase 3 study comparing Datopotamab Deruxtecan to Docetaxel in previously treated, TROP2-positive advanced or metastatic non-squamous non-sm…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
An observational study to emulate the CheckMate 017/057 trials in advanced non-small cell lung cancer using specialty oncology electronic he…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Magnetic Resonance Imaging of the Lung: Oncological Applications
A clinical trial investigating magnetic resonance imaging (MRI) applications for lung cancer imaging is currently recruiting, focusing on no…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial sponsored by Fudan University is evaluating Narlumosbart in combination with SBRT as part of first-line chemotherap…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Microbiota and the Lung Cancer [NA]
This clinical trial explores the relationship between the microbiota and non-small cell lung cancer, with the study currently active but not…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations [Phase 2]
Phase 2 trial evaluating Andamertinib with or without platinum-doublet chemotherapy versus platinum-doublet chemotherapy in patients with No…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 trial investigating the safety and efficacy of osimertinib in combination with amivantamab for non-small cell lung cancer with commo…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases
An update on a study that uses specialty oncology electronic health records to emulate the KEYNOTE-042 trial in advanced or metastatic non-s…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Safety and Efficacy of NK510 to Treat NSCLC [EARLY_Phase 1]
This clinical trial update indicates NK510 is being investigated for non-small cell lung cancer in an early-phase study and the trial is cur…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance [Phase 2]
Phase 2 trial evaluating MRI surveillance to reduce symptomatic brain metastases in patients with stage III non-small cell lung cancer.